Ads
related to: aromatase inhibitors for menopause over the counter medication names- Coverage Lookup
Utilize the Coverage Lookup Tool to
Help Patients View Insurance Info
- Savings & Support
Learn About Savings & Access Info
For Your VMS Patients & Practice.
- Discover Resources
Download Physician Resources And
Learn How to request Samples.
- Common FAQs
Explore FAQs and Get Your Burning
Questions Answered Now.
- See Important Safety Info
Review Safety & Tolerability Info
For An FDA-Approved VMS Treatment.
- Discover The MOA
Learn About The Mechanism Of Action
For An FDA-Approved VMS Treatment.
- Coverage Lookup
Search results
Results From The WOW.Com Content Network
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, [1] [2] and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. They may also be used for chemoprevention in women at high risk for breast cancer.
ATD has many names in sports supplements including: 1,4,6 etiollochan-dione, 3, 17-keto-etiochol-triene, androst-1,4,6-triene-3,17-dione and many others. These all refer to CAS# 633-35-2. ATD may cause a positive test for the anabolic steroid Boldenone, of which it is a possible metabolite and production contaminant. ATD is also prohibited in ...
Exemestane is known chemically as 6-methylideneandrosta-1,4-diene-3,17-dione. Like the aromatase inhibitors formestane and atamestane, exemestane is a steroid that is structurally similar to 4-androstenedione, the natural substrate of aromatase. It is distinguished from the natural substance only by the methylidene group in position 6 and an ...
This page was last edited on 18 September 2023, at 00:24 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer for post-menopausal women. [1]It was patented in 1986 and approved for medical use in 1996. [4]
Non-Steroidal Aromatase Inhibitors (NSAIs) are one of two categories of aromatase inhibitors (AIs). AIs are divided into two categories, steroidal aromatase inhibitors (SAIs, type 1 inhibitors) and non-steroidal aromatase inhibitors (type 2 inhibitors) that is based on their mechanism of action and structure.
Ad
related to: aromatase inhibitors for menopause over the counter medication names